Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-09-24 16:49 Tx date 2021-09-09 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,865
+83,000 vol $0.2032 each |
||
Filed 2021-09-24 15:56 Tx date 2021-09-24 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,003,718 vol |
1,446,575 | |
Filed 2021-09-24 15:52 Tx date 2021-09-09 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,865
+83,000 vol $0.2032 each |
442,857 | |
Filed 2021-09-24 15:52 Tx date 2021-09-09 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,865
+83,000 vol $0.2032 each |
||
Filed 2021-09-24 15:29 Tx date 2021-09-03 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-276,956 vol |
276,857 | |
Filed 2021-09-24 14:31 Tx date 2021-09-24 |
$VRT
Veritas Pharma Inc. |
Lowther, Blair Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1160170 BC LTD (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,074,157 vol |
1,354,157 | |
Filed 2021-09-23 11:26 Tx date 2021-09-01 |
$VRT
Veritas Pharma Inc. |
Lowther, Blair Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1160170 BC LTD (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-280,000 vol |
280,000 | |
Filed 2021-09-23 11:17 Tx date 2021-09-01 |
$VRT
Veritas Pharma Inc. |
Lowther, Blair Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1160170 BC LTD (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
+280,000 vol |
||
Filed 2021-09-15 20:22 Tx date 2021-09-15 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,020
+3,000 vol $0.34 each |
61,400 | |
Filed 2021-09-15 20:22 Tx date 2021-09-14 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,422
+13,400 vol $0.33 each |
58,400 | |
Filed 2021-09-15 20:21 Tx date 2021-09-13 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+25,000 vol $0.26 each |
45,000 | |
Filed 2021-09-15 20:20 Tx date 2021-09-10 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+20,000 vol $0.25 each |
20,000 | |
Filed 2021-09-15 20:12 Tx date 2020-08-25 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Holder: Cheryl McFadden (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-15 20:09 Tx date 2021-09-09 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,857
+83,000 vol $0.2031 each |
636,813 | |
Filed 2021-09-10 18:10 Tx date 2021-09-09 |
$VRT
Veritas Pharma Inc. |
matvieshen, michael
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+20,000 vol |
3,120,000 | |
Filed 2020-08-25 16:29 Tx date 2020-08-25 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
202,623 | ||
Filed 2020-08-25 16:28 Tx date 2020-08-25 |
$VRT
Veritas Pharma Inc. |
McFadden, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
553,813 | ||
Filed 2020-08-06 17:40 Tx date 2020-07-30 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,749
+423,333 vol $0.075 each |
423,333 | |
Filed 2020-08-06 16:12 Tx date 2020-07-30 |
$VRT
Veritas Pharma Inc. |
Lowther, Blair Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1160170 BC LTD (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
+560,000 vol |
560,000 | |
Filed 2020-08-06 16:09 Tx date 2018-11-20 |
$VRT
Veritas Pharma Inc. |
Lowther, Blair Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1160170 BC LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-07-31 13:26 Tx date 2020-07-28 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37.50
-500 vol $0.075 each |
0 | |
Filed 2020-07-31 00:39 Tx date 2020-07-28 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-52.50
-500 vol $0.105 each |
500 | |
Filed 2020-07-31 00:38 Tx date 2020-07-28 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,176.90
-19,790 vol $0.11 each |
1,000 | |
Filed 2020-07-31 00:37 Tx date 2020-07-28 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-600.00
-5,000 vol $0.12 each |
20,790 | |
Filed 2020-07-31 00:36 Tx date 2020-07-28 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,495
-13,000 vol $0.115 each |
25,790 | |
Filed 2020-07-31 00:35 Tx date 2020-07-28 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,512.50
-12,500 vol $0.121 each |
38,790 | |
Filed 2020-07-23 19:27 Tx date 2020-07-23 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,175
-14,500 vol $0.15 each |
51,290 | |
Filed 2020-07-23 19:24 Tx date 2020-07-23 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,250
-15,000 vol $0.15 each |
||
Filed 2020-04-17 10:53 Tx date 2020-04-04 |
$VRT
Veritas Pharma Inc. |
matvieshen, michael
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,100,000 | ||
Filed 2019-02-15 Tx date 2018-12-19 |
$VRT
Veritas Pharma Inc. |
Douglas, Darwin
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,250,000 | ||
Filed 2019-02-14 Tx date 2018-11-20 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
Filed 2019-02-14 Tx date 2018-12-18 |
$VRT
Veritas Pharma Inc. |
Miller, Landon
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,458,333 | ||
Filed 2019-02-14 Tx date 2018-11-20 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
65,790 | ||
Filed 2019-02-14 Tx date 2018-11-20 |
$VRT
Veritas Pharma Inc. |
Standish, Nick
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-17 Tx date 2018-06-25 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-160,000
-250,000 vol $0.64 each |
0 | |
Filed 2018-08-17 Tx date 2018-06-25 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-160,000
-250,000 vol $0.64 each |
||
Filed 2018-07-10 Tx date 2018-05-23 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,762.50
-6,500 vol $0.425 each |
||
Filed 2018-07-10 Tx date 2018-06-04 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,555
-31,000 vol $0.405 each |
6,325,000 | |
Filed 2018-07-10 Tx date 2018-06-04 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,580
-36,000 vol $0.405 each |
||
Filed 2018-07-10 Tx date 2018-05-23 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,828
-40,000 vol $0.4207 each |
6,403,500 | |
Filed 2018-07-10 Tx date 2018-05-23 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,800
-40,000 vol $0.42 each |
||
Filed 2018-07-10 Tx date 2018-05-23 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,734.55
-6,500 vol $0.4207 each |
6,443,500 | |
Filed 2018-07-10 Tx date 2018-05-23 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,775.50
-6,500 vol $0.427 each |
||
Filed 2018-07-10 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,814.75
-49,500 vol $0.4205 each |
6,450,000 | |
Filed 2018-07-10 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,790
-49,500 vol $0.42 each |
||
Filed 2018-07-10 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-210.25
-500 vol $0.4205 each |
6,499,500 | |
Filed 2018-07-10 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-212.50
-500 vol $0.425 each |
||
Filed 2018-06-28 Tx date 2018-06-25 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-160,000
-250,000 vol $0.64 each |
0 | |
Filed 2018-06-08 Tx date 2018-06-06 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,200
-3,000 vol $0.40 each |
6,317,000 | |
Filed 2018-06-05 Tx date 2018-06-04 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,580
-36,000 vol $0.405 each |
6,320,000 | |
Filed 2018-06-04 Tx date 2018-06-01 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,480
-16,000 vol $0.405 each |
6,356,000 | |
Filed 2018-06-01 Tx date 2018-05-31 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,757.50
-31,500 vol $0.405 each |
6,372,000 | |
Filed 2018-05-23 Tx date 2018-05-23 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,800
-40,000 vol $0.42 each |
6,403,500 | |
Filed 2018-05-23 Tx date 2018-05-23 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,762.50
-6,500 vol $0.425 each |
6,443,500 | |
Filed 2018-05-18 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,790
-49,500 vol $0.42 each |
6,450,000 | |
Filed 2018-05-18 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-212.50
-500 vol $0.425 each |
6,499,500 | |
Filed 2018-05-18 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,790
-49,500 vol $0.42 each |
||
Filed 2018-05-18 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,790
-49,500 vol $0.42 each |
||
Filed 2018-05-18 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-212.50
-500 vol $0.425 each |
||
Filed 2018-05-18 Tx date 2018-05-17 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-212.50
-500 vol $0.425 each |
||
Filed 2018-04-19 Tx date 2017-12-21 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Options
47 - Acquisition or disposition by gift
|
$-112,500
-250,000 vol $0.45 each |
250,000 | |
Filed 2018-04-19 Tx date 2017-01-11 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
Filed 2018-04-19 Tx date 2017-01-11 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-18 Tx date 2017-12-21 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$160,000
+250,000 vol $0.64 each |
450,000 | |
Filed 2018-03-09 Tx date 2018-03-01 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-200,000
-400,000 vol $0.50 each |
400,000 | |
Filed 2018-03-09 Tx date 2018-02-21 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
50 - Grant of options
|
$260,000
+400,000 vol $0.65 each |
800,000 | |
Filed 2018-03-09 Tx date 2018-03-01 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-103,368
-175,200 vol $0.59 each |
376,050 | |
Filed 2018-03-09 Tx date 2018-03-01 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$200,000
+400,000 vol $0.50 each |
551,250 | |
Filed 2018-02-05 Tx date 2018-01-02 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
51 - Exercise of options
|
$-49,000
-50,000 vol $0.98 each |
||
Filed 2018-02-05 Tx date 2018-01-02 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-50,500
-50,000 vol $1.01 each |
316,250 | |
Filed 2018-02-05 Tx date 2018-01-02 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-10,100
-10,000 vol $1.01 each |
366,250 | |
Filed 2018-02-05 Tx date 2018-01-02 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-40,000
-40,000 vol $1.00 each |
376,250 | |
Filed 2018-02-05 Tx date 2018-01-02 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-21,420
-21,000 vol $1.02 each |
416,250 | |
Filed 2018-02-05 Tx date 2018-01-02 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-28,420
-29,000 vol $0.98 each |
437,250 | |
Filed 2018-02-05 Tx date 2018-01-02 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-51,500
-50,000 vol $1.03 each |
466,250 | |
Filed 2018-02-05 Tx date 2018-01-03 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-56,400
-60,000 vol $0.94 each |
0 | |
Filed 2018-02-05 Tx date 2018-01-03 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,120
-36,500 vol $0.88 each |
60,000 | |
Filed 2018-02-05 Tx date 2018-01-03 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,115
-3,500 vol $0.89 each |
96,500 | |
Filed 2018-02-05 Tx date 2018-01-03 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-49,500
-50,000 vol $0.99 each |
100,000 | |
Filed 2018-02-05 Tx date 2018-01-03 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-18,480
-21,000 vol $0.88 each |
150,000 | |
Filed 2018-02-05 Tx date 2018-01-03 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-48,160
-56,000 vol $0.86 each |
171,000 | |
Filed 2018-02-05 Tx date 2018-01-03 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,550
-23,000 vol $0.85 each |
227,000 | |
Filed 2018-02-05 Tx date 2018-01-02 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-98,000
-100,000 vol $0.98 each |
250,000 | |
Filed 2018-02-05 Tx date 2018-01-02 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-49,000
-50,000 vol $0.98 each |
350,000 | |
Filed 2017-12-18 Tx date 2017-12-07 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,900
-10,000 vol $0.79 each |
6,430,000 | |
Filed 2017-12-18 Tx date 2017-01-11 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,500,000 | ||
Filed 2017-12-18 Tx date 2017-12-06 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,300
-15,000 vol $0.82 each |
6,485,000 | |
Filed 2017-12-18 Tx date 2017-12-07 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,100
-45,000 vol $0.78 each |
6,440,000 | |
Filed 2017-12-18 Tx date 2017-12-07 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,800
-3,500 vol $0.80 each |
6,426,500 | |
Filed 2017-12-18 Tx date 2017-12-08 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,300
-35,000 vol $0.78 each |
6,391,500 | |
Filed 2017-12-18 Tx date 2017-12-08 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,200
-26,500 vol $0.80 each |
6,365,000 | |
Filed 2017-12-18 Tx date 2017-12-11 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,800
-10,000 vol $0.78 each |
6,355,000 | |
Filed 2017-12-18 Tx date 2017-12-11 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,000
-10,000 vol $0.80 each |
6,345,000 | |
Filed 2017-12-18 Tx date 2017-12-12 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-33,750
-45,000 vol $0.75 each |
6,300,000 | |
Filed 2017-12-18 Tx date 2017-12-12 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,600
-10,000 vol $0.76 each |
6,290,000 | |
Filed 2017-12-18 Tx date 2017-12-12 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,950
-2,500 vol $0.78 each |
6,287,500 | |
Filed 2017-12-18 Tx date 2017-12-13 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,065
-1,500 vol $0.71 each |
6,286,000 | |
Filed 2017-12-18 Tx date 2017-12-15 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,100
-13,500 vol $0.60 each |
6,272,500 | |
Filed 2017-12-18 Tx date 2017-12-15 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,490
-9,000 vol $0.61 each |
6,263,500 | |
Filed 2017-12-18 Tx date 2017-12-18 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-98,100
-163,500 vol $0.60 each |
6,100,000 | |
Filed 2017-12-06 Tx date 2017-10-31 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+1,500,000 vol |
11,500,000 | |
Filed 2017-12-06 Tx date 2017-10-31 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$420,000
+1,500,000 vol $0.28 each |
6,500,000 | |
Filed 2017-11-29 Tx date 2017-11-24 |
$VRT
Veritas Pharma Inc. |
Nieken, Yari
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$112,500
+250,000 vol $0.45 each |
500,000 | |
Filed 2017-09-27 Tx date 2017-09-20 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$45,000
+100,000 vol $0.45 each |
516,250 | |
Filed 2017-09-27 Tx date 2017-01-09 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$60,000
+200,000 vol $0.30 each |
216,250 | |
Filed 2017-09-27 Tx date 2017-09-20 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$28,000
+100,000 vol $0.28 each |
332,500 | |
Filed 2017-09-27 Tx date 2017-01-09 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$100,000
+200,000 vol $0.50 each |
416,250 | |
Filed 2017-09-06 Tx date 2017-09-06 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$420,000
+1,400,000 vol $0.30 each |
||
Filed 2017-09-06 Tx date 2017-01-04 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$250,000
+5,000,000 vol $0.05 each |
10,000,000 | |
Filed 2017-09-06 Tx date 2017-09-06 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$420,000
+1,400,000 vol $0.30 each |
||
Filed 2017-09-06 Tx date 2017-09-06 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$420,000
+1,400,000 vol $0.30 each |
||
Filed 2017-09-06 Tx date 2017-01-04 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
97 - Other
|
+5,000,000 vol |
||
Filed 2017-09-06 Tx date 2017-01-04 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
97 - Other
|
$250,000
+5,000,000 vol $0.05 each |
||
Filed 2017-09-06 Tx date 2017-01-04 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
5,000,000 | ||
Filed 2017-09-06 Tx date 2017-09-06 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$420,000
+1,400,000 vol $0.30 each |
||
Filed 2017-08-30 Tx date 2017-01-11 |
$VRT
Veritas Pharma Inc. |
Sampson, Linda Joy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
Filed 2017-08-30 Tx date 2017-01-04 |
$VRT
Veritas Pharma Inc. |
Marapharm Ventures Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,000,000 | ||
Filed 2017-05-15 Tx date 2017-01-17 |
$VRT
Veritas Pharma Inc. |
Nieken, Yari
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
Filed 2017-03-14 Tx date 2017-03-03 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
50 - Grant of options
|
$200,000
+400,000 vol $0.50 each |
400,000 | |
Filed 2017-03-05 Tx date 2017-02-28 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-96,000
-300,000 vol $0.32 each |
100,000 | |
Filed 2017-03-05 Tx date 2017-02-28 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-45,000
-100,000 vol $0.45 each |
0 | |
Filed 2017-03-05 Tx date 2017-02-28 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$45,000
+100,000 vol $0.45 each |
||
Filed 2017-03-05 Tx date 2017-02-28 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-96,000
-300,000 vol $0.32 each |
||
Filed 2017-03-05 Tx date 2017-02-28 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$96,000
+300,000 vol $0.32 each |
||
Filed 2017-03-05 Tx date 2017-02-28 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-200,800
-400,000 vol $0.50 each |
151,250 | |
Filed 2017-03-05 Tx date 2017-02-28 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$144,000
+400,000 vol $0.36 each |
551,250 | |
Filed 2017-03-01 Tx date 2017-02-24 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,520
-23,500 vol $0.32 each |
76,500 | |
Filed 2017-03-01 Tx date 2017-02-24 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-50,000 vol $0.32 each |
||
Filed 2017-03-01 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,455
-23,500 vol $0.53 each |
-123,500 | |
Filed 2017-03-01 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,500
-50,000 vol $0.51 each |
||
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,500
-50,000 vol $0.51 each |
||
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,500
-50,000 vol $0.51 each |
||
Filed 2017-02-27 Tx date 2017-02-17 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-45,000
-100,000 vol $0.45 each |
-100,000 | |
Filed 2017-02-27 Tx date 2017-02-16 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+100,000 vol $0.45 each |
||
Filed 2017-02-27 Tx date 2017-02-16 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+100,000 vol $0.45 each |
||
Filed 2017-02-27 Tx date 2017-02-24 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-50,000 vol $0.32 each |
50,000 | |
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-50,000 vol $0.32 each |
||
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-50,000 vol $0.32 each |
||
Filed 2017-02-27 Tx date 2017-02-17 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,000
-100,000 vol $0.32 each |
||
Filed 2017-02-27 Tx date 2017-02-17 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,000
-100,000 vol $0.32 each |
||
Filed 2017-02-27 Tx date 2017-02-17 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,000
-100,000 vol $0.32 each |
100,000 | |
Filed 2017-02-27 Tx date 2017-02-23 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,500
-50,000 vol $0.51 each |
-150,000 | |
Filed 2017-02-04 Tx date 2017-01-18 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$100,000
+200,000 vol $0.50 each |
232,500 | |
Filed 2017-01-31 Tx date 2017-01-11 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
50 - Grant of options
|
$45,000
+100,000 vol $0.45 each |
400,000 | |
Filed 2016-11-24 Tx date 2016-09-06 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$32,000
+100,000 vol $0.32 each |
400,000 | |
Filed 2016-11-24 Tx date 2015-12-01 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
32,500 | ||
Filed 2016-11-24 Tx date 2015-12-01 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
16,250 | ||
Filed 2016-11-22 Tx date 2016-11-22 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,500
-50,000 vol $0.39 each |
0 | |
Filed 2016-11-22 Tx date 2016-08-08 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-11-22 Tx date 2016-11-22 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,000
+50,000 vol $0.34 each |
50,000 | |
Filed 2016-09-30 Tx date 2016-09-29 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
Filed 2016-09-30 Tx date 2016-08-08 |
$VRT
Veritas Pharma Inc. |
Hamilton, Matthew
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-27 Tx date 2016-09-06 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
50 - Grant of options
|
$96,000
+300,000 vol $0.32 each |
300,000 | |
Filed 2016-09-06 Tx date 2016-09-02 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-50,000
-200,000 vol $0.25 each |
0 | |
Filed 2016-09-06 Tx date 2016-08-31 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
10 - Acquisition or disposition in the public market
|
$-50,540
-140,000 vol $0.361 each |
||
Filed 2016-09-06 Tx date 2016-08-31 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
10 - Acquisition or disposition in the public market
|
$-50,540
-140,000 vol $0.361 each |
||
Filed 2016-09-06 Tx date 2016-08-31 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-50,540
-140,000 vol $0.361 each |
151,250 | |
Filed 2016-09-06 Tx date 2016-08-31 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$50,000
+200,000 vol $0.25 each |
291,250 | |
Filed 2016-09-06 Tx date 2016-08-31 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-50,540
-140,000 vol $0.361 each |
||
Filed 2016-09-06 Tx date 2016-08-31 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-50,540
-140,000 vol $0.361 each |
||
Filed 2016-09-06 Tx date 2016-08-31 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,000
+200,000 vol $0.25 each |
||
Filed 2016-09-06 Tx date 2016-08-31 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,000
+200,000 vol $0.25 each |
||
Filed 2016-09-02 Tx date 2016-01-07 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-02 Tx date 2016-01-07 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
Filed 2016-05-18 Tx date 2016-01-07 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-05-18 Tx date 2016-04-23 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
$34,218
+45,625 vol $0.75 each |
45,625 | |
Filed 2016-05-18 Tx date 2016-04-25 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$36,500
+91,250 vol $0.40 each |
91,250 | |
Filed 2016-05-18 Tx date 2016-01-07 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-05-13 Tx date 2016-05-09 |
$VRT
Veritas Pharma Inc. |
Birmingham, Jason
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+37,500 vol $0.40 each |
987,500 | |
Filed 2016-05-13 Tx date 2016-05-09 |
$VRT
Veritas Pharma Inc. |
Birmingham, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+18,750 vol |
18,750 | |
Filed 2016-05-13 Tx date 2014-08-07 |
$VRT
Veritas Pharma Inc. |
Birmingham, Jason
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-02-08 Tx date 2016-01-07 |
$VRT
Veritas Pharma Inc. |
Alexander, David Malcolm
5 - Senior Officer of Issuer
Holder: 482130 B.C. Ltd. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
Filed 2016-02-05 Tx date 2015-12-01 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-02-05 Tx date 2015-12-01 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-02-05 Tx date 2016-01-04 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+300,000 vol $0.25 each |
||
Filed 2016-02-05 Tx date 2016-01-04 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-02-05 Tx date 2015-12-01 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-02-05 Tx date 2016-01-04 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+300,000 vol $0.25 each |
300,000 | |
Filed 2016-02-05 Tx date 2016-01-04 |
$VRT
Veritas Pharma Inc. |
Franciosi, Luigi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+300,000 vol $0.25 each |
||
Filed 2016-02-04 Tx date 2016-02-03 |
$VRT
Veritas Pharma Inc. |
Spina, Domenico
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
Filed 2016-01-08 Tx date 2015-12-22 |
$VRT
Veritas Pharma Inc. |
Werden, Leonard
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-30,000
-300,000 vol $0.10 each |
0 | |
Filed 2016-01-08 Tx date 2015-12-22 |
$VRT
Veritas Pharma Inc. |
Werden, Leonard
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$30,000
+300,000 vol $0.10 each |
300,000 | |
Filed 2016-01-08 Tx date 2016-01-04 |
$VRT
Veritas Pharma Inc. |
Werden, Leonard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+300,000 vol $0.25 each |
300,000 | |
Filed 2016-01-07 Tx date 2016-01-05 |
$VRT
Veritas Pharma Inc. |
Birmingham, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 |